Tobacco company Philip Morris International (NYSE:PM) will be reporting earnings tomorrow before market open. Here’s what investors should know. Philip Morris beat analysts’ revenue ...

Philip Morris delivered strong Q4 results, surpassing EPS and revenue estimates, driven by surging demand for non-traditional products like IQOS and ZYN. Non-traditional products now represent 40% ...

Needham initiated coverage of Philip Morris International (NYSE:PM) on Thursday with a Buy rating.Analyst Gerald Pascarelli noted that Philip Morris (NYSE:PM) has already made great strides in ...

Philip Morris is up 20% since the beginning of the year, and at $145.32 per share, has set a new 52-week high. Investors who bought $1,000 worth of Philip Morris’s shares 5 years ago would now ...

Philip Morris once again turned in a beat-and-raise quarter. Zyn and IQOS both saw strong volume growth in the quarter. Despite recent gains, the stock still looks like a buy. Let's dig into the ...

Three years after raising health groups’ suspicions by acquiring Vectura, a British pharmaceutical firm that makes asthma inhalers, cigarette giant Philip Morris International has made a deal to ...

Philip Morris International said Tuesday it is planning to invest $600 million to open a manufacturing plant in Colorado to keep up with steep demand for Zyn nicotine pouches. The tobacco giant ...